Eyenovia Stock (NASDAQ:EYEN), Quotes and News Summary

Q: What sector and industry does Eyenovia (EYEN) operate in?

Eyenovia is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Eyenovia Stock (NASDAQ: EYEN) stock price, news, charts, stock research, profile.

Open	$0.540
Close	$0.531
Volume / Avg.	575.667K / 1.152M
Day Range	0.520 - 0.545
52 Wk Range	0.501 - 5.850
Market Cap	$25.494M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	23
Short Interest	12.68%
Days to Cover	3.01

Recent News

Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones index closed higher by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.

Avi Kapoor

Beyond Cataract Surgery: Analyst Highlights Broader Market Potential For Eyenovia/Formosa's Steroid For Post-Eye Surgery Pain, Inflammation

FDA-approved clobetasol propionate ophthalmic suspension 0.05% (APP13007) by Formosa Pharma & AimMax. Breakthrough post-ocular surgery relief, first in 15 years. Eyenovia partnership. $1.3 billion market entry. Clinically superior Phase 3 results.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Eyenovia Inc

Sector

Health Care

Industry

Pharmaceuticals

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on i...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Eyenovia (EYEN) stock?

You can purchase shares of Eyenovia (NASDAQ: EYEN) through any online brokerage.

View our list of the best stock brokerages.

Who are Eyenovia's (EYEN) competitors?

Other companies in Eyenovia’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Ocuphire Pharma (NASDAQ:OCUP).

What is the target price for Eyenovia (EYEN) stock?

The latest price target for Eyenovia (NASDAQ: EYEN) was reported by HC Wainwright & Co. on Tuesday, March 19, 2024. The analyst firm set a price target for 12.00 expecting EYEN to rise to within 12 months (a possible 2130.48% upside). 8 analyst firms have reported ratings in the last year.

Current Stock Price for Eyenovia (EYEN)?

The stock price for Eyenovia (NASDAQ: EYEN) is $0.538 last updated April 18, 2024 at 7:56 PM EDT.

Does Eyenovia (EYEN) pay a dividend?

There are no upcoming dividends for Eyenovia.

When is Eyenovia (NASDAQ:EYEN) reporting earnings?

Eyenovia’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is Eyenovia (EYEN) going to split?

There is no upcoming split for Eyenovia.

What sector and industry does Eyenovia (EYEN) operate in?

Eyenovia is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-